KAYLA CASSIUM: Open Payments
NPI 1366194961 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 15 payments from 9 companies in 2025. Trend: 2023 $330 · 2024 $196 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| Verona Pharma, Inc. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| Lundbeck LLC | 1 | $35 |
| Lilly USA, LLC | 1 | $30 |
| Exact Sciences Corporation | 1 | $27 |
| Amgen Inc. | 1 | $20 |
Products named: Wegovy, Ohtuvayre, XIFAXAN, UBRELVY, ELIQUIS, REXULTI, JARDIANCE, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
